当前位置：
X-MOL 学术
›
Eur. J. Nucl. Med. Mol. Imaging
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
First-in-human administration of [161Tb]Tb-SibuDAB and comparative dosimetry with standard [177Lu]Lu-PSMA-I&T as part of the PROGNOSTICS phase Ia study
European Journal of Nuclear Medicine and Molecular Imaging ( IF 8.6 ) Pub Date : 2024-12-05 , DOI: 10.1007/s00259-024-07009-w Alin Chirindel, Guillaume P. Nicolas, Frida Westerbergh, Lisa McDougall, David E. Schmid, Susanne Geistlich, Viviane J. Tschan, Sarah D. Busslinger, Angelique Fokkema, Nicola Aceto, Peter Bernhardt, Nicholas P. van der Meulen, Cristina Müller, Damian Wild, Roger Schibli
中文翻译：
作为预后 Ia 期研究的一部分，首次人体施用 [161Tb]Tb-SibuDAB 和与标准 [177Lu]Lu-PSMA-I&T 的剂量测定
更新日期：2024-12-05
European Journal of Nuclear Medicine and Molecular Imaging ( IF 8.6 ) Pub Date : 2024-12-05 , DOI: 10.1007/s00259-024-07009-w Alin Chirindel, Guillaume P. Nicolas, Frida Westerbergh, Lisa McDougall, David E. Schmid, Susanne Geistlich, Viviane J. Tschan, Sarah D. Busslinger, Angelique Fokkema, Nicola Aceto, Peter Bernhardt, Nicholas P. van der Meulen, Cristina Müller, Damian Wild, Roger Schibli
中文翻译：
作为预后 Ia 期研究的一部分，首次人体施用 [161Tb]Tb-SibuDAB 和与标准 [177Lu]Lu-PSMA-I&T 的剂量测定
京公网安备 11010802027423号